Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Blose, Robert Strausberg

Stephen Blose has been elected to be chairman of BioMicro Systems, the company said this week. Blose has been a member of BioMicro’s board for three years.
 
Blose is CEO of Mill Valley Summit Group, which offers services and consulting for venture capital firms and life science companies.
 
Blose also has been a division general manager at Bio-Rad, working on commercializing DNA, informatics, and other systems. Before that he was president and CEO of Protein Databases.
 

 
The J. Craig Venter Institute is shuffling some of its executive staff while it restructures its two research divisions — The Institute for Genomic Research and the Center for the Advancement of Genomics — into several focused units.
 
The institute said that Craig Venter will remain JCVI chairman and president; Robert Strausberg will move from his job as president of the TCAG division to become deputy director of the JCVI; and Marv Frazier will shift from vice president of research at TCAG to become executive vice president of research of JCVI.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.